Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Items 901–1,000 of 1,000
La mésaventure thérapeutique du paracétamol chez le buveur excessif
Louvet, A., Boitard, J., Dharancy, S., Duriez, A., Deltenre, P., Paris, J.-C., & Mathurin, P. (2006) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(06)73312-7 · Cited by 14
Propylthiouracil-induced hepatotoxicity.
Hardee, J. T., Barnett, A. L., Thannoun, A., Eghtesad, B., Wheeler, D., & Jamal, M. M. (1996) · Europe PMC (PubMed Central) · Cited by 13
East meets West: Acute liver failure in the global village
Bowen, D. G., Shackel, N. A., & McCaughan, G. W. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02182.x · Cited by 13
Toxicogenomics in Biomarker Discovery
DeCristofaro, M. F., & Daniels, K. K. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-048-9_9 · Cited by 13
Nrf2 in Host Defense: Over the Rainbow
Cho, H., Kwak, M., & Pi, J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/975839 · Cited by 13
Microfluidic gut-axis-on-a-chip models for pharmacokinetic-based disease models
Kim, R., & Sung, J. H. (2024) · Biomicrofluidics · doi:10.1063/5.0206271 · Cited by 13
A novel NIR-II fluorescent probe for hydrogen peroxide detection in drug-induced liver injury
Chen, H., Zhou, H., Zhang, X., Ding, Y., Zhang, X., Xu, Q., Wang, B., Yin, C., & Fan, Q. (2024) · Chemical Communications · doi:10.1039/d4cc03512g · Cited by 12
Tuberculosis Pharmacogenetics: State of The Art
Teixeira, R. L. D. F., Lopes, M. Q. P., Noel, P., & Rezende, A. (2013) · InTech eBooks · doi:10.5772/54984 · Cited by 12
CONCENTRATION-EFFECT, INCIDENCE AND MECHANISM OF NEVIRAPINE HEPATOTOXICITY
Elias (2013) · American Journal of Pharmacology and Toxicology · doi:10.3844/ajptsp.2013.20.30 · Cited by 12
Ponamarev, V. S., Popova, O. S., Kostrova, A., & Agafonova, L. A. (2023) · AIP conference proceedings · doi:10.1063/5.0161091 · Cited by 12
Losartan-induced ischemic hepatocellular hepatotoxicity: A case report and literature review
Shaaban, H. S., Al-Halawani, M., Thawabi, M., Asslo, F., Shamoon, F. E., & Baddoura, W. (2014) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.141635 · Cited by 13
The Poisoned Child in the Pediatric Intensive Care Unit
Hanhan, U. A. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.02.010 · Cited by 12
Drug-Induced Liver Injury Caused by Adalimumab: A Case Report and Review of the Bibliography
Frider, B., Bruno, A., Ponte, M. L., & Amante, M. F. (2013) · Case Reports in Hepatology · doi:10.1155/2013/406901 · Cited by 16
Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database
Petronijević, M., Ilić, K., & Suzuki, A. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2115 · Cited by 14
Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort
Shantakumar, S., Landis, S., Lawton, A., & Hunt, C. M. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.03.019 · Cited by 12
Ebrahimi, M., Mousavi, S. R., Toussi, A. G., Reihani, H., & Bagherian, F. (2015) · PubMed Central · doi:10.14661/1310 · Cited by 12
Albendazole-induced toxic hepatitis: A case report
Editorial Office (2013) · The Turkish Journal of Gastroenterology · doi:10.4318/tjg.2013.0426 · Cited by 13
High-Resolution Mass Spectrometry in Metabolite Identification
Ladumor, M. K., Tiwari, S., Patil, A., Bhavsar, K., Jhajra, S., Prasad, B., & Singh, S. (2016) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2016.01.004 · Cited by 13
Exploring an animal model of amodiaquine-induced liver injury in rats and mice
Liu, F., Cai, P., Metushi, I. G., Li, J., Nakayawa, T., Vega, L., & Uetrecht, J. (2016) · Journal of Immunotoxicology · doi:10.3109/1547691x.2016.1166167 · Cited by 12
Drug Toxicities of Common Analgesic Medications in the Emergency Department
Ciejka, M., Nguyen, K., Bluth, M. H., & Dubey, E. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.07.003 · Cited by 16
Sibiude, J., Warszawski, J., Tubiana, R., Chenadec, J. L., Meier, F., Faye, A., Blanche, S., Mandelbrot, L., & the ANRS-French Perinatal Cohort Study Group (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001963 · Cited by 13
Goda, K., Muta, K., Yasui, Y., Oshida, S.-I., Kitatani, K., & Takekoshi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133141 · Cited by 13
Aripiprazole reduces liver cell division
Marolt, T. P., Kramar, B., Rozman, K. B., Šuput, D., & Milisav, I. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240754 · Cited by 15
Rogalewski, A., Zuhorn, F., Wilkens, L., Krüger, M., Klingebiel, R., & Schäbitz, W. (2021) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2021.100464 · Cited by 13
CANCER CHEMOTHERAPY AND HEPATOTOXICITY: AN UPDATE
Joshi, M. S., Sodhi, K. S., Pandey, R., Singh, J., Goyal, S., Prasad, S., Kaur, H., Bhaskar, N., & Mahajan, S. (2014) · Indo American Journal of Pharmaceutical Research · Cited by 12
Acute liver injury related to the use of niperotidine
Gasbarrini, A., Gentiloni, N., Febbraro, S., Gasbarrini, A., Campli, C. D., Cesana, M., Miglio, F., Miglioli, M., Ghinelli, F., D'Ambrosi, A., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80365-0 · Cited by 12
Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient
Godart, B., Boinot, C., Remblier, C., Hajjar, A., & Beauchant, M. (2005) · Gut · doi:10.1136/gut.2005.076232 · Cited by 12
Commercialization Challenges Associated with Induced Pluripotent Stem Cell-Based Products
Smith, D. (2010) · Regenerative Medicine · doi:10.2217/rme.10.50 · Cited by 15
Moole, H. V., Ahmed, Z., Saxena, N., Puli, S. R., & Dhillon, S. (2015) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v5.28746 · Cited by 12
Karabacak, M., Kanbur, M., Eraslan, G., Siliğ, Y., Sarıca, Z. S., Tekeli, M. Y., & Taş, A. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-2382-7 · Cited by 13
Kim, J. H., Yoon, H., Lee, H., Park, H., Park, C., Dho, Y., & Hwang, J. (2019) · Acta Neurochirurgica · doi:10.1007/s00701-019-04053-6 · Cited by 12
Hay, J. E. (2004) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-004-0005-5 · Cited by 12
Howard, S. C., Ribeiro, R. C., & Pui, C. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.030 · Cited by 12
Zeng, G., Eslick, G. D., & Weltman, M. (2023) · iLiver · doi:10.1016/j.iliver.2023.05.002 · Cited by 13
Carvedilol-Induced Liver Injury, a Rare Cause of Mixed Hepatitis: A Clinical Case
Rua, J., Prata, A. R., Marques, R., Silva, R., Gomes, B., Fraga, J. B. D. P., & Fortuna, J. (2018) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000490205 · Cited by 12
Drug Discovery and Development
Link, W. (2019) · Springer eBooks · doi:10.1007/978-3-030-18722-4_4 · Cited by 12
Identification of proteome markers for drug-induced liver injury in zebrafish embryos
Driessen, M., van der Plas-Duivesteijn, S. J., Kienhuis, A. S., van den Brandhof, E., Roodbergen, M., van de Water, B., Spaink, H. P., Palmblad, M., van der Ven, L. T. M., & Pennings, J. L. A. (2022) · Toxicology · doi:10.1016/j.tox.2022.153262 · Cited by 11
Current and prospective therapies for acute liver failure
Brown, S. A., Axenfeld, E., Stonesifer, E., Hutson, W. R., Hanish, S. I., Raufman, J., & Urrunaga, N. H. (2018) · Disease-a-Month · doi:10.1016/j.disamonth.2018.04.002 · Cited by 11
Tight junction stabilization prevents HepaRG cell death in drug-induced intrahepatic cholestasis
Sonoi, R., & Hagihara, Y. (2021) · Biology Open · doi:10.1242/bio.058606 · Cited by 12
Tostmann, A., Boeree, M. J., Harries, A. D., Sauvageot, D., Banda, H. T., & Zijlstra, E. E. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2007.01871.x · Cited by 11
Synthesis and the hepatoprotective activity of dibenzocyclooctadiene lignan derivatives
He, T., Wang, Q.-Y., Shi, J.-Z., Fan, T., Yan, C., Huang, L., Liu, S., Hao, X., & Mu, S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.02.020 · Cited by 11
Bolesta, S., & Roslund, B. P. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070164 · Cited by 11
Successful Treatment of Fosinopril-Induced Severe Cholestatic Jaundice with Plasma Exchange
Chou, J., Yu, C., Chuang, P., Lai, H., Hsu, C.-H., Cheng, K.-S., Peng, C.-Y., & Chiang, I. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l229 · Cited by 11
COMPETITIVE INHIBITORS OF ENZYMES AND THEIR THERAPEUTIC APPLICATION
Bjelaković, G., Stojanović, I. R., Bjelaković, G., Pavlovic, D. D., Kocic, G. M., & Daković-Milić, A. (2002) · Cited by 11
Fitzgerald, D. A. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709030-00009 · Cited by 11
Ibrutinib-induced acute liver failure
Kahn, A., Horsley‐Silva, J. L., Lam-Himlin, D. M., Reeder, C. B., Douglas, D. D., & Carey, E. J. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1346251 · Cited by 11
Prediction of Human Liver Toxicity Using In Vitro Assays: Limitations and Opportunities
Atienzar, F., & Nicolas, J.-M. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_7 · Cited by 12
LC–MS-Based Metabolomics in the Study of Drug-Induced Liver Injury
Lu, Y., Zhao, X., Hu, Z., Wang, L. A., & Li, F. (2018) · Current Pharmacology Reports · doi:10.1007/s40495-018-0144-3 · Cited by 11
Protective role of c‐Jun N‐terminal kinase‐2 (JNK2) in ibuprofen‐induced acute liver injury
Zoubek, M. E., Woitok, M. M., Sydor, S., Nelson, L. J., Bechmann, L. P., Lucena, M. I., Andrade, R. J., Bast, A., Koek, G. H., Trautwein, C., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5174 · Cited by 11
Pregnane X receptor in drug-induced liver injury: Friend or foe?
Shehu, A. I., & Ma, X. (2018) · Liver Research · doi:10.1016/j.livres.2018.12.002 · Cited by 13
PROSPECTIVE MONITORING OF DRUG USE: DRUG-INDUCED LIVER INJURY IN A PRIMARY HEALTHCARE CENTER
Prado, N. M. D. B. L., Messias, G. C., Santos, G., Nunes, V., Schinonni, M. I., & Paraná, R. (2019) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.201900000-73 · Cited by 11
Rabello, G. D., Forte, L. V., & Galvão, A. C. R. (2000) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2000000100014 · Cited by 11
Hepatitis during Chloroguanide Prophylaxis
Oostweegel, L. M., Beijnen, J. H., & Mulder, J. W. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17273 · Cited by 11
(2005) · Humana Press eBooks · doi:10.1385/1592598323 · Cited by 11
Greaves, P. (2000) · Elsevier eBooks · doi:10.1016/b978-044450514-9/50008-5 · Cited by 11
Predicting Human Adverse Drug Reactions from Nonclinical Safety Studies
Valentin, J., Keisu, M., & Hammond, T. G. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse203 · Cited by 11
Zhang, L., Bushel, P. R., Chou, J.-H., Zhou, T., & Watkins, P. B. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00162 · Cited by 10
Role of immune dysfunction in drug induced liver injury
Girish, C., & Sanjay, S. (2021) · World Journal of Hepatology · doi:10.4254/wjh.v13.i11.1677 · Cited by 11
Bhardwaj, R., Ivans, A., Stringfellow, J., Morris, B. A., Coric, V., Croop, R. S., & Bertz, R. (2023) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1244 · Cited by 10
Ajadi, A. R., Oladele, S. G., Ebenezer, B. O., & Olajide, B. K. (2013) · International Journal of Morphology · doi:10.4067/s0717-95022013000100044 · Cited by 10
Çizginer, S., Tatlı, S., Hurwitz, S., Tuncali, K., vanSonnenberg, E., & Silverman, S. G. (2011) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.12.033 · Cited by 10
Assob, J. C. N. (2014) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000288 · Cited by 10
Zhang, T.-G., Wang, Y., Zhao, J., Xia, M., Peng, S., & Ikejima, T. (2016) · Toxicology Research · doi:10.1039/c5tx00470e · Cited by 10
Drug-Induced Liver Injury - Tantangan dalam Diagnosis
Loho, I. M., & Hasan, I. (2014) · Cermin Dunia Kedokteran · Cited by 18
Zhang, Y. V., Fan, S., & Kellogg, M. D. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.10.019 · Cited by 10
Mitochondrial Respiratory Complexes as Targets of Drugs: The PPAR Agonist Example
Bottoni, P., Pontoglio, A., Scarà, S., Pieroni, L., Urbani, A., & Scatena, R. (2022) · Cells · doi:10.3390/cells11071169 · Cited by 10
Activatable Optical Probes for Fluorescence and Photoacoustic Imaging of Drug‐Induced Liver Injury
Chen, L., Xu, Z. C., & Jiang, X. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200097 · Cited by 12
Physiology and Anatomy of the Liver
Mulaikal, T. A., & Emond, J. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-64298-7_1 · Cited by 12
García, L. C. M., A., D. C. F., & A., D. G. F. (2010) · Revista Med · doi:10.18359/rmed.1314 · Cited by 24
Ikterus und schwere Leberfunktionsst�rung bei der hormonablativen Behandlung des Prostatakarzinoms
L�bbert, C., Wiese, M., Haupt, R., & Ruf, B. (2004) · Der Internist · doi:10.1007/s00108-003-1114-2 · Cited by 10
Vector Analysis to Detect Hepatotoxicity Signals in Drug Development
Trost, D. C., & Freston, J. W. (2008) · Drug Information Journal · doi:10.1177/009286150804200106 · Cited by 10
Muthulinga, M. (2008) · Journal of Pharmacology and Toxicology · doi:10.3923/jpt.2008.75.83 · Cited by 10
Fulminant hepatic failure in children
Gugig, R., & Rosenthal, P. J. (2008) · Therapy · doi:10.2217/14750708.5.4.451 · Cited by 10
Disorders of the Liver and Biliary Tract
Guss, D. A., & Oyama, L. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-05472-0.00088-8 · Cited by 10
Andritsou, F., Benetou, V., Michail, K. A., Pantazis, N., & Pavlopoulou, I. D. (2017) · BioMed Research International · doi:10.1155/2017/5242048 · Cited by 10
Marquetand, C., Langer, H. F., Klein, J. P., & Graf, T. (2020) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2020-0014 · Cited by 10
Larson, A. M. (2008) · Disease-a-Month · doi:10.1016/j.disamonth.2008.03.008 · Cited by 15
DeVeaugh‐Geiss, A., Kadakia, A., Chilcoat, H. D., Alexander, L. R., & COPLAN, P. M. (2015) · Journal of Pain · doi:10.1016/j.jpain.2015.03.004 · Cited by 10
Altered CD38 expression in thioacetamide‐induced rat model of liver cirrhosis
Gan, B. H., Ng, G. L., Bay, B., & Chang, C. F. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01173.x · Cited by 10
Overby, C. L., Weng, C., Haerian, K., Perotte, A., Friedman, C., & Hripcsak, G. M. (2013) · PubMed Central · Cited by 11
Preparing for the New Anticoagulants
Davidson, B. L. (2003) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000014593.16147.bf · Cited by 10
Cornwell, P. D., & Ulrich, R. G. (2007) · Toxicologic Pathology · doi:10.1080/01926230701383194 · Cited by 10
Unerwünschte Arzneimittelwirkungen: Diagnostik und Bewertung
Thürmann, P. (2005) · Der Pathologe · doi:10.1007/s00292-005-0805-y · Cited by 12
Krankheiten der Leber und Gallenwege
Reiser, M., Heringlake, S., Mölleken, C., & Schmiegel, W. (2012) · Springer eBooks · doi:10.1007/978-3-642-21081-5_14 · Cited by 10
Anh, N. K., Tung, P. M., Kim, M. J., Long, N. P., Cho, Y., Kim, D., & Shin, J. (2022) · Molecules · doi:10.3390/molecules27238607 · Cited by 9
Adverse Drug Reactions in Older Adults: a Retrospective Study from Pharmacovigilance
Charfi, R., Aïdli, S. E., Zaïem, A., Kastalli, S., Sraïri, S., Daghfous, R., & Lakhal, M. (2012) · Therapies · doi:10.2515/therapie/2012059 · Cited by 9
Biochemical Indices of Drug Toxicity
Ofori, E. K. (2022) · Springer eBooks · doi:10.1007/978-3-031-12398-6_20 · Cited by 13
A Review on the Role of Phytoconstituents Chrysin on the Protective Effect on Liver and Kidney
Sarmah, D. K., & Sengupta, R. (2023) · Current Drug Discovery Technologies · doi:10.2174/0115701638242317231018144944 · Cited by 9
Hepatotoxicity effect of some Iranian medicinal herbal formulation on rats
Asgary, S., Movahedian, A., Mansoorkhani, H., & Keshvari, M. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.124641 · Cited by 9
A guidance for renal biomarker lead optimization and use in translational pharmacodynamics
Ozer, J. S. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.12.001 · Cited by 9
Case report: jin bu huan--not so benign herbal medicine.
Divinsky, M. (2002) · PubMed Central · Cited by 9
Shahid, M. M., & Subhan, F. (2014) · Cited by 11
A monkey model of acetaminophen-induced hepatotoxicity; phenotypic similarity to human
Tamai, S., Iguchi, T., Niino, N., Mikamoto, K., Sakurai, K., Sayama, A., Shimoda, H., Takasaki, W., & Mori, K. (2017) · The Journal of Toxicological Sciences · doi:10.2131/jts.42.73 · Cited by 9
El‐Taher, E. M., El-Sherei, M. M., Dine, R. S. E., Elnaggar, D. M. Y., Khalil, W. K. B., Kassem, S. M., Elkhateeb, A., & Kassem, M. E. S. (2021) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-020-00527-6 · Cited by 10
Current Models for Predicting Drug-induced Cholestasis: The Role of Hepatobiliary Transport System.
Jazaeri, F., Sheibani, M., Nezamoleslami, S., Moezi, L., & Dehpour, A. R. (2021) · PubMed Central · doi:10.22037/ijpr.2020.113362.14254 · Cited by 10
PITB: A high affinity transthyretin aggregation inhibitor with optimal pharmacokinetic properties.
Pinheiro, F., Varejão, N., Sánchez-Morales, A., Bezerra, F., Navarro, S., Velázquez-Campoy, A., Busqué, F., Almeida, M. R., Alibés, R., Reverter, D., et al. (2023) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2023.115837 · Cited by 9
Gao, Z. (2009) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e31819946aa · Cited by 9
Syed, A. A., & Adams, C. (2012) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2012.12010 · Cited by 9
Ramm, S., Morissey, B., Hernández, B., Rooney, C., Pennington, S. R., & Mally, A. (2015) · Toxicology · doi:10.1016/j.tox.2015.03.004 · Cited by 9
Sertraline reduces glutamate uptake in human platelets
Rodrigues, D. O., Bristot, I. J., Klamt, F., & Frizzo, M. E. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.10.014 · Cited by 9
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.